Advertisement
Research ArticlePediatrics
Open Access

Quantitative Susceptibility Mapping of Venous Vessels in Neonates with Perinatal Asphyxia

A.M. Weber, Y. Zhang, C. Kames and A. Rauscher
American Journal of Neuroradiology July 2021, 42 (7) 1327-1333; DOI: https://doi.org/10.3174/ajnr.A7086

Abstract

BACKGROUND AND PURPOSE: Cerebral venous oxygen saturation can be used as an indirect measure of brain health, yet it often requires either an invasive procedure or a noninvasive technique with poor sensitivity. We aimed to test whether cerebral venous oxygen saturation could be measured using quantitative susceptibility mapping, an MR imaging technique, in 3 distinct groups: healthy term neonates, injured term neonates, and preterm neonates.

MATERIALS AND METHODS: We acquired multiecho gradient-echo MR imaging data in 16 neonates with perinatal asphyxia and moderate or severe hypoxic-ischemic encephalopathy (8 term age: average, 40.0 [SD, 0.8]  weeks’ gestational age; 8 preterm, 33.5 [SD, 2.0]  weeks’ gestational age) and in 8 healthy term-age controls (39.3 [SD, 0.6] weeks, for a total of n = 24. Data were postprocessed as quantitative susceptibility mapping images, and magnetic susceptibility was measured in cerebral veins by thesholding out 99.95% of lower magnetic susceptibility values.

RESULTS: The mean magnetic susceptibility value of the cerebral veins was found to be 0.36 (SD, 0.04) ppm in healthy term neonates, 0.36 (SD, 0.06) ppm in term injured neonates, and 0.29 (SD, 0.04) ppm in preterm injured neonates. Correspondingly, the derived cerebral venous oxygen saturation values were 73.6% (SD, 2.8%), 71.5% (SD, 7.4%), and 72.2% (SD, 5.9%). There was no statistically significant difference in cerebral venous oxygen saturation among the 3 groups (P = .751).

CONCLUSIONS: Quantitative susceptibility mapping–derived oxygen saturation values in preterm and term neonates agreed well with values in past literature. Cerebral venous oxygen saturation in preterm and term neonates with hypoxic-ischemic encephalopathy, however, was not found to be significantly different between neonates or healthy controls.

ABBREVIATIONS:

χ
magnetic susceptibility
CSaO2
cerebral arterial oxygen saturation
CSvO2
cerebral venous oxygen saturation
Hct
hematocrit
HIE
hypoxic-ischemic encephalopathy
NIRS
near-infrared resonance spectroscopy
QSM
quantitative susceptibility mapping
SSS
superior sagittal sinus
TRUST
T2-relaxation-under-spin tagging

Perinatal asphyxia is the condition resulting from the deprivation of oxygen to a neonate and can lead to brain tissue damage or death. Asphyxia at birth can affect virtually any organ, but the brain is of the highest concern because it is the least likely to quickly or completely heal.1 Hypoxic-ischemic encephalopathy (HIE) occurs when the entire brain is deprived of an adequate supply of oxygen and can result in neurologic disability, such as cerebral palsy, mental retardation, and epilepsy. HIE occurs in 1.5 per 1000 live births2 and is the fifth leading cause of death worldwide in children younger than 5 years of age (8%).3

Currently, the severity of HIE is mainly assessed by clinical parameters and conventional MR imaging and can be classified into mild, moderate, or severe categories.4,5 While identifying HIE in term infants is generally well-characterized, its identification in preterm infants remains complex, with variable inclusion criteria being discussed and reported.6⇓⇓-9 More accurate markers would be useful for detection, classification, early therapeutic interventions, and predictors of long-term outcome. Several studies have investigated various alternative methods for measuring HIE, such as DWI,10 MR spectroscopy,11,12 urinary nuclear MR metabolomic profiling,13 and visual evoked potentials,14 with varying levels of reported success.

Cerebral venous oxygen saturation (CSvO2) is the amount of leftover oxygen in the veins after oxygen delivery and extraction by the brain and can act as a surrogate of brain oxygen consumption. The oxygen supply is of critical importance to brain function because neurons rely predominantly on aerobic metabolism for their energy demands. In infants who have experienced birth asphyxia, CBF has been reported to be markedly elevated.15 When the brain is hyperperfused like this, elevated CSvO2 values would signal a “luxury perfusion” state, suggesting serious brain damage.16 Normal CSvO2 values, meanwhile, would suggest intact coupling between CBF and metabolic needs.17 Thus, knowing the CSvO2 in preterm and term infants who are suspected of having HIE could provide clinicians with invaluable information. Unfortunately, the 2 current methods for measuring CSvO2 require either the invasive insertion of an internal jugular vein catheter for co-oximetry or a blood gas analyzer, or the noninvasive use of near-infrared resonance spectroscopy (NIRS). NIRS, however, has been shown to have poor sensitivity at low CSvO2 compared with co-oximetry and can reach a depth of only a few millimeters.18

Quantitative susceptibility mapping (QSM)19,20 examines gradient-echo phase data, usually acquired with SWI,21 to determine local tissue magnetic susceptibility (χ). Because deoxyhemoglobin in the venous blood is paramagnetic, a decrease in χ of venous blood compared with the surrounding brain tissue will indicate increased CSvO2. Thus, QSM, a noninvasive method, may provide an indirect measure of CSvO2.22,23 For example, Doshi et al,24 in 2015, reported increased CSvO2 in adults following mild traumatic brain injury. Similarly, Chai et al,25 in 2017, reported increased CSvO2 in subjects with mild traumatic brain injury compared with healthy controls, but they also reported a positive correlation of CSvO2 with postconcussive symptoms. Chai et al,26 in 2020, also reported reduced CSvO2 in patients undergoing hemodialysis, which also correlated with cognitive scores (r = 0.492, P = .02).

Thus, we set out to determine how well CSvO2 could be measured using QSM and hematocrit (Hct) from blood samples in term and preterm neonates with moderate or severe HIE and to compare those values with those of healthy term controls. We hypothesized that after perinatal asphyxia, both preterm and term neonates with moderate or severe HIE would demonstrate increased CSvO2 through decreased cerebral vein magnetic susceptibility compared with healthy term controls.

MATERIALS AND METHODS

Patients

Between January 2017 and January 2018, preterm and term neonates with a clinical history of perinatal asphyxia and moderate or severe HIE who were transferred to Children’s Hospital of Chongqing Medical University intensive care nursery were enrolled in a study evaluating the detection of brain injury by MR imaging, in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). Recruitment and scanning ended due to the neonatal ward of the hospital moving to a new branch of the hospital, where their scanners were from a different vendor, and there were no Phillips Healthcare scanners. The institution’s Committee on Clinical Research Ethics approved the study protocol, and informed consent was obtained from the parents. The inclusion criteria were determined on the basis of the definition of perinatal asphyxia and moderate or severe HIE as follows: 1) evidence of perinatal asphyxia (Apgar score of ≤7 for >5 minutes after birth or a history of acute perinatal event, placental abruption, cord prolapse, or the need for ventilation for at least 10 minutes after birth27); 2) evidence of moderate or severe HIE distinguished by using the Sarnat and Sarnat clinical stages5 for term infants and infants between 33 and 37 weeks’ gestation and significant changes in neurologic examination findings and/or seizures for infants younger than 33 weeks gestation;28 and 3) abnormal MR imaging findings in all patients on T1-weighted, T2-weighted, and FLAIR images, mainly but not only in the basal ganglia/thalami region, watershed region, and periventricular white matter caused by HIE.29,30 Subjects were sedated using 5 mg/kg of phenobarbital (intramuscular injection). Neonates with high motion or image artifacts were excluded. In total, 8 term neonates and 8 preterm neonates who were determined to have perinatal asphyxia and moderate or severe HIE were included for further study. Eight term neonates with hyperbilirubinemia who were free of other neonatal complications, such as congenital and chromosomal abnormalities and with normal MR imaging findings were recruited prospectively as healthy controls. Hct values were obtained as part of the regular clinical work-up.

MR Imaging Acquisition

Brain MR images were obtained on a 3T system (Achieva; Philips Healthcare) using an 8-channel sensitivity encoding head coil. Data for QSM were collected using a 3D gradient-echo sequence with 5 echoes (TR = 30 ms, TE1 = 4.5 ms, echo spacing = 5.5 ms, flip angle = 17°, FOV = 196 × 154 × 103 mm3, acquired voxel size = 0.50 × 0.5 × 1.0 mm3, reconstructed voxel size = 0.5 × 0.5 × 0.5 mm3, scan time = 5 minutes 9 seconds).31 Other scans included the following: inversion recovery turbo spin-echo T1-weighted (TR/TI = 7000/600 ms, TE = 15 ms, section thickness = 5 mm, FOV = 160 × 151 × 98 mm3, acquisition matrix = 220 × 163, scan time = 2 minutes 17 seconds); turbo spin-echo T2-weighted (TR = 5000 ms, TE = 100 ms, section thickness = 5 mm, FOV = 160 × 149 × 98 mm3, acquisition matrix = 332 × 205, scan time = 1 minute 38 seconds); and fast FLAIR images (TR/TI = 12,000/2850 ms, TE = 140 ms, section thickness = 5 mm, FOV = 160 × 149 × 98 mm3, acquisition matrix = 176 × 144, scan time = 3 minutes 55 seconds). The total acquisition time was 13 minutes 23 seconds.

MR Imaging Analysis

QSM images of all 5 echoes were postprocessed from the phase data of the multi-gradient-echo scans. Phase unwrapping was achieved using a 3D Laplacian algorithm,32 while the background field was removed using the variable sophisticated harmonic artifact reduction for phase method.33 A Gaussian filter (σ = 0.5) was applied to the normalized field maps to smooth out high-frequency errors originating from the reconstruction steps before the inversion. A 2-step dipole inversion algorithm34 was used to solve the dipole inversion problem. The last echo was used to obtain the brain mask, which effectively removed the external cerebral veins. Using the last echo to generate the brain mask reliably removed artifacts from air-tissue and bone-tissue interfaces, eg, sinuses, especially in the later echoes, without the need for manual erosion. This QSM algorithm can be freely accessed at https://github.com/kamesy/QSM.m. Finally, only the fourth echo (TE = 21 ms) was used for measuring χ values because even echoes were flow-compensated along the readout direction and the second echo (TE =10 ms) had a poor contrast-to-noise ratio.

The χ of cerebral veins was measured by thresholding out the lowest 99.95% values of the whole brain. In the absence of intracranial hemorrhage and because neonates have very low brain iron content, voxels that reside entirely inside veins reflect the structures with the highest magnetic susceptibility values. Total blood volume is about 3%.35,36 Venous blood volume is about two-thirds of total blood volume. For a voxel to be free of partial volume effects and given the spatial resolution of 0.5 × 0.5 × 1 mm3 of the scan, only veins with an inner diameter of at least 1 mm could be included in the analysis. After thresholding, images were assessed by A.M.W. to ensure that only veins remained (Fig 1). The remaining 0.25% of χ values was then averaged to give the mean cerebral χ value for each subject. ROIs were also drawn manually on nonvein tissue by A.M.W. to calculate Δχ. Visual inspection did not reveal any germinal matrix bleeding in the deep cerebral veins.

FIG 1.
FIG 1.

Sample internal veins selected after thresholding out the lower 99.95% χ values. As can be seen in these sagittal, coronal, and axial views from a sample healthy term neonate, the major veins that were left over include the straight sinus, inferior sagittal sinus, and the internal cerebral vein. Note the weak contrast between gray and white matter and the basal ganglia due to the low myelin and iron content of the neonate brain.

Calculating CSvO2

CSvO2 was calculated using the following equation: Embedded Image

where Δχ is the susceptibility difference between venous blood and surrounding tissue, ΔEmbedded Image is the susceptibility difference per unit hematocrit between fully deoxygenated and fully oxygenated blood, Hct is the individual fractional hematocrit, and CSvO2 is the blood oxygen saturation. ΔEmbedded Image was taken to be 4 × π × 0.21, or 2.64 ppm.37,38

Statistical Analysis

Statistical analysis was performed using R 3.4.2 (2017; http://www.r-project.org/). The relationship between calculated CSvO2 and condition (healthy control, preterm injury, and term injury) was investigated using a 1-way ANOVA. Visual inspection of residual plots did not reveal any obvious deviations from homoscedasticity or normality.

RESULTS

Patient Characteristics

Demographic data and clinical characteristics for both groups (8 healthy controls, 8 term neonates, and 8 preterm neonates with perinatal asphyxia and moderate or severe HIE) are summarized in Table 1. No significant differences were found in gestational age, corrected gestational age at MR imaging, time interval between age at birth and age at MR imaging, birth weight, or sex between healthy controls and term neonates with HIE. No significant differences were found in sex, time interval between age at birth and age at MR imaging, clinical history, and symptoms and signs between term neonates and preterm neonates with perinatal asphyxia and moderate or severe HIE. As expected, a significant difference (P < .05) was found in the Apgar grade between healthy term neonates and term neonates with HIE. Between term and preterm neonates with HIE, significant differences (P < .05) were found only in gestational age, corrected gestational age at MR imaging, and birth weight, as would be expected.

View this table:
Table 1:

Demographic data and clinical characteristics of the 3 groupsa

CSvO2 Analysis

The mean χ value of the internal cerebral veins in healthy controls and term and preterm injured neonates was found to be 0.36 (SD, 0.04) ppm, 0.36 (SD, 0.06) ppm, and 0.29 (SD, 0.04) ppm, respectively, while the mean fractional Hct values were 0.52 (SD, 0.03), 0.49 (SD, 0.07), and 0.42 (SD, 0.06), respectively. Correspondingly, the derived mean CSvO2 values were 73.6% (SD, 2.8%), 71.5% (SD, 7.4%), and 72.2% (SD, 6.0%), respectively. The Cohen D effect size between each group was found to be 0.38 for healthy controls and term injured neonates; 0.30 for healthy controls and preterm neonates; and 0.10 between term injured neonates and preterm neonates. A CSvO2 boxplot among the 3 groups with individual points for each subject is shown in Fig 2. One-way ANOVA analysis did not reveal that the condition (healthy control, preterm injury, and term injury) made a significant difference among groups (P > .05). Boxplots of χ and Hct values in each group, with individual points for each subject are included in the Online Supplementary Data.

FIG 2.
FIG 2.

Boxplot of CSvO2 percentages by group. Gray circles are the ROI measurements from each subject.

DISCUSSION

In this study, we quantified CSvO2 from χ values in the internal cerebral veins of preterm and term neonates with HIE and healthy term controls. Moderate-to-severe HIE caused by intrapartum or late antepartum hypoxic-ischemic events may lead to neurodevelopmental disability.1 It is of great importance to examine cerebral hemodynamic changes in neonates with moderate or severe HIE because this examination may lead to a better understanding of the cerebral oxygen metabolism of brain injury in HIE and early therapeutic interventions. Although no statistical difference in CSvO2 values was found between healthy term controls and preterm and term infants with moderate or severe HIE, to the best of our knowledge, this is one of the first studies measuring CSvO2 using QSM in healthy term neonates, as well as the first to do so in term and preterm neonates with moderate or severe HIE. Thus, our reported values for healthy neonates as well as injured preterm and term neonates may be used in future studies for comparison purposes. These values agree well with previously reported values using other methods (Table 2).

View this table:
Table 2:

Comparison of CSvO2 percentages in fetuses and neonates in the literature

Noninvasive measurements of CSvO2 in neonates has historically been quite difficult. The current best practice, NIRS, does not provide robust and reliable measurements due to several limitations,39,40 including contamination from extracerebral tissue and arterial blood (generally 30% but can vary considerably among subjects)41 and an insensitivity to low CSvO2 levels.18 QSM, meanwhile, is a relatively new technique, which fully quantifies χ using MR imaging phase data. Because oxyhemoglobin is diamagnetic and deoxyhemoglobin is paramagnetic, a reduction in deoxyhemoglobin and an increase in oxyhemoglobin will be reflected as a decrease in the χ of venous blood. Using Hct values obtained from blood samples, one can then calculate the CSvO2.

Recently, several studies have been published demonstrating the promise22,42,43 of using QSM to quantify CSvO2 changes in brain injuries of adults.24,25 Doshi et al24 and Chai et al25 reported CSvO2 differences between adult healthy controls and subjects with mild traumatic brain injury by measuring the χ of cerebral major veins. Doshi et al found decreases in venous χ in the left thalamostriate vein and right basal vein, while Chai et al found decreases in venous χ in the straight sinus. Both of these studies suggested increased CSvO2 after a mild traumatic brain injury, with different conclusions as to what this might suggest. Doshi et al also obtained CBF measurements and found injured subjects to have significantly increased CBF postinjury. Along with the increase in CSvO2, they suggested that the brain responds to traumatic injuries by trying to protect brain tissue via the supply of more oxygen than the tissue requires. Whereas Chai et al did not acquire CBF measures but did look at the correlation of χ reductions with the amount of time post-trauma, they reported a positive correlation between the 2 measures, which indicates recovery to normal levels of oxygenation with time. Chai et al suggested that QSM can thus be used as a biomarker and to monitor progress.

Closer to our study, Yadav et al44 used QSM to measure CSvO2 in healthy fetuses (n = 21, median week of pregnancy = 31.3). They reported a mean CSvO2 of 67% (SD, 7%) in the superior sagittal sinus (SSS) vein, an external cerebral vein that is less than our reported values in internal cerebral veins in healthy controls (73.6% [SD, 2.84%]). Similarly, several studies have used a method analogous to QSM, known as MR susceptometry, which uses a susceptibility-weighted image to measure χ values on the basis of geometric assumptions (such as the SSS vein being an infinitely long cylinder). These studies reported CSvO2 values in the SSS ranging from 55.2% in neonates with congenital heart disease45 to 66% in 34-week-old healthy fetuses (Table 2).46,47

Along with the susceptibility-based methods of measuring CSvO2 in neonates and fetuses, there have been other MR imaging–related techniques worth mentioning. One such method is known as T2-relaxation-under-spin tagging (TRUST). For instance, Shetty et al,48 in 2019, reported CSvO2 changes during and after therapeutic hypothermia in neonatal HIE using TRUST. The CSvO2 was calculated by measuring 1/T2 (R2) of the SSS. They examined CSvO2 values during early hypothermia treatment (18–24 hours after initiating treatment) and after and found posttreatment CSvO2 to have been reduced from 73.2% (SD, 5.5%) (during treatment) to 68.5% (SD, 9.6%) (posttreatment). These posttreatment values agreed well with a previous study that reported 62.6% (SD, 8.3%) in healthy infants using the same method.49 While these initial reports of measuring CSvO2 using TRUST are promising, some drawbacks should be considered. On the one hand, the measurement of R2 is relatively easier to postprocess than QSM because it requires only a few simple steps. On the other hand, unlike QSM, the measurement of R2 has confounding factors such as fat, fibrosis, and edema,50 along with saturation and blooming artifacts. Additionally, the scan required for QSM provides a wealth of additional information such as R2* maps and SWI, which can be used to better characterize lesions.51 In fact, SWI is already often used in clinical settings to detect intracranial hemorrhages and other brain abnormalities and is often part of the neonatal and pediatric MR imaging protocols.52⇓-54 The scan is fast (<3 minutes on modern scanners) even at high spatial resolution (<1 mm3). Disadvantages in QSM include a range of different approaches for background field removal, dipole inversion, and referencing to other tissue.

The results of our study indicate that CSvO2 values were not found to be significantly different in injured preterm and term neonates compared with healthy term controls. One reason for this finding could be that preterm and term infants with moderate or severe HIE could have reduced CBF, which, along with a reduced oxygen metabolism, would result in CSvO2 similar to that in healthy controls. In this case, injured neonates would have reduced oxygen metabolism and, thus, compromised brain health. To test these 2 opposing theories, however, we would require additional information, such as CBF and cerebral arterial oxygen saturation (CSaO2). For instance, the oxygen extraction fraction, the percentage of oxygen used from the blood as it passes through the capillary network, can be calculated by subtracting the fraction of oxygen saturation in the cerebral arteries (CSaO2) from the fraction of oxygen saturation in the cerebral veins (CSvO2).22,23 While CSaO2 can be easily and noninvasively measured using a pulse oxygen monitor and CBF can be acquired using another MR imaging scan such as arterial spin-labeling or phase contrast,55 our study, unfortunately, did not acquire these data because they were not part of the original study design. Thus, we cannot make more conclusive statements regarding preterm and term injured brain health. An alternative explanation could be because our data show premature rupture of fetal membranes in >60% of the preterm infants, which is higher than usual. It is possible that these infants have adapted to the outside world and have CSvO2 values closer to term infants.

Two strengths of our method are as follows: The QSM algorithm is available for free on-line at https://github.com/kamesy/QSM.m for researchers and clinicians to download and use. Furthermore, our method of selecting venous susceptibility values (looking at the highest 0.25%) helps reduce human error using a completely data-driven process.

There are several limitations to the current study. Only 8 subjects from each group were examined, limiting our statistical power. We did not acquire CSaO2 or CBF measurements, which would have allowed us to examine why both preterm and term infants with moderate or severe HIE did not show statistically significant differences in CSvO2 compared with healthy controls. Furthermore, no follow-up with these patients was attempted, such as cognitive scores, which could have been used to investigate any correlations with CSvO2. In the future, we hope to add more subjects, acquire CSaO2 and CBF measurements (such as arterial spin-labeling), and perform cognitive measurements as the infants develop later in life. One piece of advice the authors wish to pass on to future researchers is the importance of acquiring and using Hct values in calculating CSvO2. Had we used a constant value for Hct, the preterm group would have been found to have a statistically significant difference in CSvO2. However, by using acquired Hct from each subject, this difference was no longer seen because Hct increases with gestational age and preterm infants were scanned at a younger gestational age.56

CONCLUSIONS

We were able to measure CSvO2 in the internal cerebral veins in healthy term, preterm, and term injured neonates. These values agree well with previously reported values in the literature. However, we did not see a difference in CSvO2, despite the presence of HIE in the term injured and preterm infants. More studies should be performed in preterm and term infants with moderate or severe HIE, while acquiring other brain oxygen metrics such as CBF and CSaO2 along with cognitive metrics as the infants develop later in life.

Footnotes

  • A.M. Weber and Y. Zhang contributed equally to this work.

  • A.M. Weber was supported by a British Columbia Children’s Hospital Research Institute, M.I.N.D. postdoctoral fellowship. A. Rauscher is supported by Canada Research Chairs and a Natural Sciences and Engineering Council of Canada grant (402039‐2011, RGPIN‐2016‐05371).

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    1. Ferriero DM
    . Neonatal brain injury. N Engl J Med 2004;351:1985–95 doi:10.1056/NEJMra041996 pmid:15525724
    CrossRefPubMed
  2. 2.↵
    1. Kurinczuk JJ,
    2. White-Koning M,
    3. Badawi N
    . Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010;86:329–38 doi:10.1016/j.earlhumdev.2010.05.010 pmid:20554402
    CrossRefPubMed
  3. 3.↵
    1. Bryce J,
    2. Boschi-Pinto C,
    3. Shibuya K, et al
    . WHO estimates of the causes of death in children. Lancet 2005;365:1147–52 doi:10.1016/S0140-6736(05)71877-8 pmid:15794969
    CrossRefPubMed
  4. 4.↵
    1. Barkovich AJ,
    2. Hajnal BL,
    3. Vigneron D, et al
    . Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol 1998;19:143–49 pmid:9432172
    Abstract
  5. 5.↵
    1. Sarnat HB,
    2. Sarnat MS
    . Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study. Arch Neurol 1976;33:696–705 doi:10.1001/archneur.1976.00500100030012 pmid:987769
    CrossRefPubMed
  6. 6.↵
    1. Chalak LF,
    2. Rollins N,
    3. Morriss MC, et al
    . Perinatal acidosis and hypoxic-ischemic encephalopathy in preterm infants of 33 to 35 weeks’ gestation. J Pediatr 2012;160:388–94 doi:10.1016/j.jpeds.2011.09.001 pmid:22033298
    CrossRefPubMed
  7. 7.↵
    1. Logitharajah P,
    2. Rutherford MA,
    3. Cowan FM
    . Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome. Pediatr Res 2009;66:222–29 doi:10.1203/PDR.0b013e3181a9ef34 pmid:19390490
    CrossRefPubMed
  8. 8.↵
    1. Laptook AR
    . Birth asphyxia and hypoxic-ischemic brain injury in the preterm infant. Clin Perinatol 2016;43:529–45 doi:10.1016/j.clp.2016.04.010 pmid:27524452
    CrossRefPubMed
  9. 9.↵
    1. Salhab WA,
    2. Perlman JM
    . Severe fetal acidemia and subsequent neonatal encephalopathy in the larger premature infant. Pediatr Neurol 2005;32:25–29 doi:10.1016/j.pediatrneurol.2004.06.016 pmid:15607600
    CrossRefPubMed
  10. 10.↵
    1. Rana L,
    2. Sood D,
    3. Chauhan R, et al
    . MR imaging of hypoxic ischemic encephalopathy: distribution patterns and ADC value correlations. Eur J Radiol Open 2018;5:215–20 doi:10.1016/j.ejro.2018.08.001 pmid:30480058
    CrossRefPubMed
  11. 11.↵
    1. Azzopardi D,
    2. Edwards AD
    . Magnetic resonance biomarkers of neuroprotective effects in infants with hypoxic ischemic encephalopathy. Semin Fetal Neonatal Med 2010;15:261–69 doi:10.1016/j.siny.2010.03.001 pmid:20359970
    CrossRefPubMed
  12. 12.↵
    1. Thayyil S,
    2. Chandrasekaran M,
    3. Taylor A, et al
    . Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 2010;125:e382-395 doi:10.1542/peds.2009-1046 pmid:20083516
    Abstract/FREE Full Text
  13. 13.↵
    1. Skappak C,
    2. Regush S,
    3. Cheung P-Y, et al
    . Identifying hypoxia in a newborn piglet model using urinary NMR metabolomic profiling. PLoS ONE 2013;8:e65035 doi:10.1371/journal.pone.0065035 pmid:23741447
    CrossRefPubMed
  14. 14.↵
    1. Cainelli E,
    2. Trevisanuto D,
    3. Cavallin F, et al
    . Evoked potentials predict psychomotor development in neonates with normal MRI after hypothermia for hypoxic-ischemic encephalopathy. Clin Neurophysiol 2018;129:1300–06 doi:10.1016/j.clinph.2018.03.043 pmid:29689487
    CrossRefPubMed
  15. 15.↵
    1. Pryds O,
    2. Greisen G,
    3. Lou H, et al
    . Vasoparalysis associated with brain damage in asphyxiated term infants. J Pediatr 1990;117:119–25 doi:10.1016/S0022-3476(05)72459-8 pmid:2115079
    CrossRefPubMed
  16. 16.↵
    1. Lassen NA
    . The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 1966;2:1113–15 doi:10.1016/S0140-6736(66)92199-4 pmid:4162534
    CrossRefPubMed
  17. 17.↵
    1. Skov L,
    2. Pryds O,
    3. Greisen G, et al
    . Estimation of cerebral venous saturation in newborn infants by near infrared spectroscopy. Pediatr Res 1993;33:52–55doi:10.1203/00006450-199301000-00011 pmid:8433861
    CrossRefPubMed
  18. 18.↵
    1. Rescoe E,
    2. Tang X,
    3. Perry DA, et al
    . Cerebral near-infrared spectroscopy insensitively detects low cerebral venous oxygen saturations after stage 1 palliation. J Thorac Cardiovasc Surg 2017;154:1056–62 doi:10.1016/j.jtcvs.2017.03.154 pmid:28599970
    CrossRefPubMed
  19. 19.↵
    1. Shmueli K,
    2. de Zwart JA,
    3. van Gelderen P, et al
    . Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009;62:1510–22 doi:10.1002/mrm.22135 pmid:19859937
    CrossRefPubMed
  20. 20.↵
    1. Deistung A,
    2. Schweser F,
    3. Reichenbach JR
    . Overview of quantitative susceptibility mapping. NMR Biomed 2017;30:e3569 doi:10.1002/nbm.3569 pmid:27434134
    CrossRefPubMed
  21. 21.↵
    1. Haacke EM,
    2. Xu Y,
    3. Cheng Y-CN, et al
    . Susceptibility-weighted imaging (SWI). Magn Reson Med 2004;52:612–18 doi:10.1002/mrm.20198 pmid:15334582
    CrossRefPubMed
  22. 22.↵
    1. Haacke EM,
    2. Tang J,
    3. Neelavalli J, et al
    . Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging 2010;32:663–76 doi:10.1002/jmri.22276 pmid:20815065
    CrossRefPubMed
  23. 23.↵
    1. Tang J,
    2. Liu S,
    3. Neelavalli J, et al
    . Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach. Magn Reson Med 2013;69:1396–1407 doi:10.1002/mrm.24384 pmid:22736331
    CrossRefPubMed
  24. 24.↵
    1. Doshi H,
    2. Wiseman N,
    3. Liu J, et al
    . Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PLoS One 2015;10:e0118061 doi:10.1371/journal.pone.0118061 pmid:25659079
    CrossRefPubMed
  25. 25.↵
    1. Chai C,
    2. Guo R,
    3. Zuo C, et al
    . Decreased susceptibility of major veins in mild traumatic brain injury is correlated with post-concussive symptoms: a quantitative susceptibility mapping study. Neuroimage Clin 2017;15:625–32 doi:10.1016/j.nicl.2017.06.008 pmid:28664033
    CrossRefPubMed
  26. 26.↵
    1. Chai C,
    2. Wang H,
    3. Chu Z, et al
    . Reduced regional cerebral venous oxygen saturation is a risk factor for the cognitive impairment in hemodialysis patients: a quantitative susceptibility mapping study. Brain Imaging Behav 2020;14:1339–49 doi:10.1007/s11682-018-9999-5 pmid:30511117
    CrossRefPubMed
  27. 27.↵
    1. Antonucci R,
    2. Porcella A,
    3. Pilloni MD
    . Perinatal asphyxia in the term newborn. Journal of Pediatric and Neonatal Individualized Medicine 2014;3:e030269 doi:10.7363/030269
    CrossRef
  28. 28.↵
    1. Gopagondanahalli KR,
    2. Li J,
    3. Fahey MC, et al
    . Preterm hypoxic-ischemic encephalopathy. Front Pediatr 2016;4:114 doi:10.3389/fped.2016.00114 pmid:27812521
    CrossRefPubMed
  29. 29.↵
    1. Sie LT,
    2. van der Knaap MS,
    3. Oosting J, et al
    . MR patterns of hypoxic-ischemic brain damage after prenatal, perinatal or postnatal asphyxia. Neuropediatrics 2000;31:128–36 doi:10.1055/s-2000-7496 pmid:10963099
    CrossRefPubMed
  30. 30.↵
    1. Barkovich AJ,
    2. Sargent SK
    . Profound asphyxia in the premature infant: imaging findings. AJNR Am J Neuroradiol 1995;16:1837–46 pmid:8693984
    Abstract
  31. 31.↵
    1. Denk C,
    2. Rauscher A
    . Susceptibility weighted imaging with multiple echoes. J Magn Reson Imaging 2010;31:185–91 doi:10.1002/jmri.21995 pmid:20027586
    CrossRefPubMed
  32. 32.↵
    1. Schofield MA,
    2. Zhu Y
    . Fast phase unwrapping algorithm for interferometric applications. Opt Lett 2003;28:1194–96 doi:10.1364/ol.28.001194 pmid:12885018
    CrossRefPubMed
  33. 33.↵
    1. Li W,
    2. Wu B,
    3. Liu C
    . Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645–56 doi:10.1016/j.neuroimage.2010.11.088 pmid:21224002
    CrossRefPubMed
  34. 34.↵
    1. Kames C,
    2. Wiggermann V,
    3. Rauscher A
    . Rapid two-step dipole inversion for susceptibility mapping with sparsity priors. Neuroimage 2018;167:276–83 doi:10.1016/j.neuroimage.2017.11.018 pmid:29138089
    CrossRefPubMed
  35. 35.↵
    1. Leenders KL,
    2. Perani D,
    3. Lammertsma AA, et al
    . Cerebral blood flow, blood volume and oxygen utilization normal values and effect of age. Brain 1990;113:27–47 doi:10.1093/brain/113.1.27 pmid:2302536
    CrossRefPubMed
  36. 36.↵
    1. Doucette J,
    2. Wei L,
    3. Hernández-Torres E, et al
    . Rapid solution of the Bloch-Torrey equation in anisotropic tissue: application to dynamic susceptibility contrast MRI of cerebral white matter. Neuroimage 2019;185:198–207 doi:10.1016/j.neuroimage.2018.10.035 pmid:30332614
    CrossRefPubMed
  37. 37.↵
    1. Sedlacik J,
    2. Rauscher A,
    3. Reichenbach JR
    . Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn Reson Med 2007;58:1035–44 doi:10.1002/mrm.21283 pmid:17969121
    CrossRefPubMed
  38. 38.↵
    1. Portnoy S,
    2. Milligan N,
    3. Seed M, et al
    . Human umbilical cord blood relaxation times and susceptibility at 3 T: human umbilical cord blood relaxation times and susceptibility at 3 T. Magn Reson Med 2018;79:3194–3206 doi:10.1002/mrm.26978 pmid:29067745
    CrossRefPubMed
  39. 39.↵
    1. Ferrari M,
    2. Mottola L,
    3. Quaresima V
    . Principles, techniques, and limitations of near infrared spectroscopy. Can J Appl Physiol 2004;29:463–87 doi:10.1139/h04-031 pmid:15328595
    CrossRefPubMed
  40. 40.↵
    1. Davies DJ,
    2. Su Z,
    3. Clancy MT, et al
    . Near-infrared spectroscopy in the monitoring of adult traumatic brain injury: a review. J Neurotrauma 2015;32:933–41 doi:10.1089/neu.2014.3748 pmid:25603012
    CrossRefPubMed
  41. 41.↵
    1. Murkin JM,
    2. Arango M
    . Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaes 2009;103(Suppl 1):i3–13 doi:10.1093/bja/aep299 pmid:20007987
    CrossRefPubMed
  42. 42.↵
    1. Fan AP,
    2. Bilgic B,
    3. Gagnon L, et al
    . Quantitative oxygenation venography from MRI phase. Magn Reson Med 2014;72:149–59 doi:10.1002/mrm.24918 pmid:24006229
    CrossRefPubMed
  43. 43.↵
    1. Liu S,
    2. Buch S,
    3. Chen Y, et al
    . Susceptibility-weighted imaging: current status and future directions. NMR Biomed 2017;30:10.1002/nbm.3552 doi:10.1002/nbm.3552 pmid:27192086
    CrossRefPubMed
  44. 44.↵
    1. Yadav BK,
    2. Buch S,
    3. Krishnamurthy U, et al
    . Quantitative susceptibility mapping in the human fetus to measure blood oxygenation in the superior sagittal sinus. Eur Radiol 2019;29:2017–26 doi:10.1007/s00330-018-5735-1 pmid:30276673
    CrossRefPubMed
  45. 45.↵
    1. Jain V,
    2. Buckley EM,
    3. Licht DJ, et al
    . Cerebral oxygen metabolism in neonates with congenital heart disease quantified by MRI and optics. J Cereb Blood Flow Metab 2014;34:380–88 doi:10.1038/jcbfm.2013.214 pmid:24326385
    CrossRefPubMed
  46. 46.↵
    1. Yadav BK,
    2. Krishnamurthy U,
    3. Buch S, et al
    . Imaging putative foetal cerebral blood oxygenation using susceptibility weighted imaging (SWI). Eur Radiol 2018;28:1884–90 doi:10.1007/s00330-017-5160-x pmid:29247352
    CrossRefPubMed
  47. 47.↵
    1. Neelavalli J,
    2. Jella PK,
    3. Krishnamurthy U, et al
    . Measuring venous blood oxygenation in fetal brain using susceptibility-weighted imaging. J Magn Reson Imaging 2014;39:998–1006 doi:10.1002/jmri.24245 pmid:24783243
    CrossRefPubMed
  48. 48.↵
    1. Shetty AN,
    2. Lucke AM,
    3. Liu P, et al
    . Cerebral oxygen metabolism during and after therapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy: a feasibility study using magnetic resonance imaging. Pediatr Radiol 2019;49:224–33 doi:10.1007/s00247-018-4283-9 pmid:30402807
    CrossRefPubMed
  49. 49.↵
    1. Liu P,
    2. Huang H,
    3. Rollins N, et al
    . Quantitative assessment of global cerebral metabolic rate of oxygen (CMRO2) in neonates using MRI. NMR Biomed 2014;27:332–40 doi:10.1002/nbm.3067 pmid:24399806
    CrossRefPubMed
  50. 50.↵
    1. Wang Y,
    2. Spincemaille P,
    3. Liu Z, et al
    . Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care. J Magn Reson Imaging 2017;46:951–71 doi:10.1002/jmri.25693 pmid:28295954
    CrossRefPubMed
  51. 51.↵
    1. Zhang Y,
    2. Rauscher A,
    3. Kames C, et al
    . Quantitative analysis of punctate white matter lesions in neonates using quantitative susceptibility mapping and R2* relaxation. AJNR Am J Neuroradiol 2019;40:1221–26 doi:10.3174/ajnr.A6114 pmid:31221632
    Abstract/FREE Full Text
  52. 52.↵
    1. Bosemani T,
    2. Poretti A,
    3. Huisman TA
    . Susceptibility-weighted imaging in pediatric neuroimaging. J Magn Reson Imaging 2014;40:530–44 doi:10.1002/jmri.24410 pmid:24925729
    CrossRefPubMed
  53. 53.↵
    1. Tortora D,
    2. Severino M,
    3. Malova M, et al
    . Variability of cerebral deep venous system in preterm and term neonates evaluated on MR SWI venography. AJNR Am J Neuroradiol 2016;37:2144–49 doi:10.3174/ajnr.A4877 pmid:27469213
    Abstract/FREE Full Text
  54. 54.↵
    1. Albayram MS,
    2. Smith G,
    3. Tufan F, et al
    . Frequency, extent, and correlates of superficial siderosis and ependymal siderosis in premature infants with germinal matrix hemorrhage: an SWI study. AJNR Am J Neuroradiol 2020;41:331–37 doi:10.3174/ajnr.A6371 pmid:31919140
    Abstract/FREE Full Text
  55. 55.↵
    1. Dolui S,
    2. Wang Z,
    3. Wang DJ, et al
    . Comparison of non-invasive MRI measurements of cerebral blood flow in a large multisite cohort. J Cereb Blood Flow Metab 2016;36:1244–56 doi:10.1177/0271678X16646124 pmid:27142868
    CrossRefPubMed
  56. 56.↵
    1. Jopling J,
    2. Henry E,
    3. Wiedmeier SE, et al
    . Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics 2009;123:e333–37 doi:10.1542/peds.2008-2654 pmid:19171584
    Abstract/FREE Full Text
  57. 57.
    1. van der Hoeven MA,
    2. Maertzdorf WJ,
    3. Blanco CE
    . Continuous central venous oxygen saturation (SCvO2) measurement using a fiber optic catheter in newborn infants. Arch Dis Child Fetal Neonatal Ed 1996;74:F177–81 doi:10.1136/fn.74.3.f177 pmid:8777680
    Abstract/FREE Full Text
  58. 58.
    1. Buchvald FF,
    2. Kesje K,
    3. Greisen G
    . Measurement of cerebral oxyhaemoglobin saturation and jugular blood flow in term healthy newborn infants by near-infrared spectroscopy and jugular venous occlusion. Biol Neonate 1999;75:97–103 doi:10.1159/000014084 pmid:9852360
    CrossRefPubMed
  59. 59.
    1. Wintermark P,
    2. Hansen A,
    3. Warfield SK, et al
    . Near-infrared spectroscopy versus magnetic resonance imaging to study brain perfusion in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neuroimage 2014;85:287–93 doi:10.1016/j.neuroimage.2013.04.072 pmid:23631990
    CrossRefPubMed
  60. 60.
    1. De Vis JB,
    2. Petersen ET,
    3. Alderliesten T, et al
    . Non-invasive MRI measurements of venous oxygenation, oxygen extraction fraction and oxygen consumption in neonates. Neuroimage 2014;95:185–92 doi:10.1016/j.neuroimage.2014.03.060 pmid:24685437
    CrossRefPubMed
  • Received December 7, 2020.
  • Accepted after revision January 14, 2021.
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Citation Tools
Quantitative Susceptibility Mapping of Venous Vessels in Neonates with Perinatal Asphyxia
A.M. Weber, Y. Zhang, C. Kames, A. Rauscher
American Journal of Neuroradiology Jul 2021, 42 (7) 1327-1333; DOI: 10.3174/ajnr.A7086
Reddit logo Twitter logo Facebook logo Mendeley logo
Purchase

Jump to section

Advertisement